Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 76: | Line 76: | ||
|FQR | |FQR | ||
| | | | ||
| | | | ||
|- | |- | ||
| Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease | | Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease | ||
| Line 114: | Line 114: | ||
|FQR | |FQR | ||
| | | | ||
| | | | ||
|- | |- | ||
| Systemic Mastocytosis||Disease | | Systemic Mastocytosis||Disease | ||
| Line 1,396: | Line 1,396: | ||
|Emailed 28/3/2022 for progress update | |Emailed 28/3/2022 for progress update | ||
|- | |- | ||
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando | |ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki Manando (fellow), Fabiola Quintero-Rivera | ||
| | | | ||
| | | | ||
| Line 1,402: | Line 1,402: | ||
| ||GC | | ||GC | ||
| | | | ||
|Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. | |Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added. FQR emailed Manando on 4/12/23 | ||
|- | |- | ||
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera | |Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera | ||